motexafin gadolinium

• CAT Number: M136381
• CAS Number: 156436-89-4
• Molecular Formula: C₅₂H₇₄GdN₅O₁₄^-
• Molecular Weight: 1150.40
• Purity: ≥95%
• Storage: Store at -20C
• IUPAC Name: acetic acid;3-[4,5-diethyl-24-(3-hydroxypropyl)-16,17-bis[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]-10,23-dimethyl-13,20,25,26-tetraza-27-azanidapentacyclo[20.2.1.13,6.18,11.014,19]heptacosa-1(25),2,4,6,8(26),9,11,13,15,17,19,21,23-tridecaen-9-yl]propan-1-ol;gadolinium
• InChI: InChI=1S/C48H66N5O10.2C2H4O2.Gd/c1-7-35-36(8-2)40-28-42-38(12-10-14-55)34(4)46(53-42)32-50-44-30-48(63-26-24-61-22-20-59-18-16-57-6)47(62-25-23-60-21-19-58-17-15-56-5)29-43(44)49-31-45-33(3)37(11-9-13-54)41(52-45)27-39(35)51-40;2*1-2(3)4;/h27-32,54-55H,7-26H2,1-6H3;2*1H3,(H,3,4);/q-1
• InChIKey: AARXZCZYLAFQQU-UHFFFAOYSA-N
• SMILES: CCC1=C(C2=CC3=NC(=CN=C4C=C(C(=CC4=NC=C5C(=C(C(=N5)C=C1[N-]2)CCCO)C)OCCOCCOCCOC)OCCOCCOCCOC)C(=C3CCCO)C)CC.CC(=O)O.CC(=O)O.[Gd]

Motexafin gadolinium（Cat No.:M136381） is a novel redox-active drug that accumulates in tumor cells and has been studied for its potential in cancer therapy. It functions by generating reactive oxygen species (ROS) upon exposure to light, leading to oxidative stress and cell death. Motexafin gadolinium has shown promise in preclinical studies and early-phase clinical trials for various cancers, including brain metastases and prostate cancer. Its ability to target cancer cells specifically, along with its potential for use in photodynamic therapy, makes it a candidate for further investigation as a therapeutic agent in oncology.